ClinicalTrials.Veeva

Menu

Muscle Ultrasound Study in Shock Patients (MUSiShock)

University Hospitals (UH) logo

University Hospitals (UH)

Status

Completed

Conditions

Septic Shock

Treatments

Other: Medical Research Council (MRC) sum score
Other: Diaphragm ultrasound (DUS)
Other: Peripheral Muscle Ultrasound (PMUS)
Other: Airway occlusion pressure (P0.1)

Study type

Observational

Funder types

Other

Identifiers

NCT04550143
2020-00452

Details and patient eligibility

About

Intensive Care Unit (ICU) patients are known to lose muscle mass and function for many reasons, ranging from prolonged immobilization, to the effects of ICU treatments such as mechanical ventilation (MV), to the critical illness itself. Ultrasonography (US) is widely used in the ICU setting and has greatly evolved in the last decades, since it allows the non-invasive assessment of different structures, using radiation-free and user-friendly technology; its application for the assessment or the skeletal muscle is a promising tool and might help detecting muscle changes and thus several dysfunctions during early stages of ICU stay.

By using skeletal muscle ultrasound at both diaphragm and peripheral levels, the overall aim of this study is to improve knowledge in the early detection of muscle dysfunction and weakness , and their relationship with mechanical ventilation weaning and muscle strength, in critically ill patients suffering from septic shock.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. adult patients (> 18 years old) admitted to the ICU
  2. with a diagnosis of septic shock
  3. a SOFA score equal or superior to 8 points, at ICU admission
  4. blood lactate concentration above 2 mmol/L, at ICU admission
  5. expected to have more than 48h of mechanical ventilation (estimated by the attending physician)
  6. expected to stay more than 5 days in the unit (estimated by the attending physician)
  7. able to walk prior to ICU admission / walking aids accepted;

Exclusion criteria

  1. pregnancy
  2. lower limb amputation, fixators or open wounds
  3. thoracic fixators or open wounds
  4. diagnosed neuromuscular or central nervous system diseases
  5. being transferred from another ICU
  6. spinal cord injury
  7. diaphragm pacemaker
  8. palliative goals of care
  9. cancers derived sarcopenia
  10. cachexia
  11. anorexic disorders (protein-energy malnutrition)
  12. intellectual or cognitive impairments, limiting the ability to follow instructions.

Trial design

30 participants in 1 patient group

Septic Shock
Treatment:
Other: Airway occlusion pressure (P0.1)
Other: Peripheral Muscle Ultrasound (PMUS)
Other: Medical Research Council (MRC) sum score
Other: Diaphragm ultrasound (DUS)

Trial contacts and locations

1

Loading...

Central trial contact

Karim Bendjelid, MD, PhD; Ivo Neto Silva, PT, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems